Fundraising September 15, 2024 – October 1, 2024 About fundraising

Volume 7; Issue 2

Vaccine

Volume 7; Issue 2
2

Editorial

Year:
1989
Language:
english
File:
PDF, 98 KB
english, 1989
3

ICRC ‘anti-leprosy vaccine’

Year:
1989
Language:
english
File:
PDF, 254 KB
english, 1989
4

New cholera vaccines

Year:
1989
Language:
english
File:
PDF, 372 KB
english, 1989
5

Anti-fertility vaccines

Year:
1989
Language:
english
File:
PDF, 571 KB
english, 1989
12

Stability of an antifertility vaccine consisting of gonadotropin subunits linked to tetanus toxoid

Year:
1989
Language:
english
File:
PDF, 227 KB
english, 1989
13

Expression of a poliovirus type 1 neutralization epitope on a diphtheria toxin fusion protein

Year:
1989
Language:
english
File:
PDF, 540 KB
english, 1989
15

Formation and characterization of FeLV ISCOMs

Year:
1989
Language:
english
File:
PDF, 572 KB
english, 1989
23

Genes encoding Mycobacterium tuberculosis protein antigens useful for tuberculosis vaccine preparation and therapy

Year:
1989
Language:
english
File:
PDF, 135 KB
english, 1989
29

Expression of precore-core or preS1-preS2-S genes of hepatitis B virus in vertebrate, e.g. mouse NIH3T3, cell culture

Year:
1989
Language:
english
File:
PDF, 140 KB
english, 1989
30

Cattle leukaemia vaccine containing recombinant vaccinia virus incorporating cattle leukaemia virus surface antigen gene

Year:
1989
Language:
english
File:
PDF, 140 KB
english, 1989
33

Production of a hepatitis B virus surface antigen polypeptide and vaccine protein sequence

Year:
1989
Language:
english
File:
PDF, 133 KB
english, 1989
37

New retrovirus related to HIV virus-1 from T-lymphocyte cell culture derived from paraparesis patients after activation

Year:
1989
Language:
english
File:
PDF, 133 KB
english, 1989
38

Vector containing yeast arg3 regulatory region used for production of hepatitis B virus surface antigen for use in vaccine

Year:
1989
Language:
english
File:
PDF, 133 KB
english, 1989
39

Putative failures of recombinant DNA hepatitis B vaccines

Year:
1989
Language:
english
File:
PDF, 232 KB
english, 1989
41

Oral Immunization Symposium: 21–22 March 1988, Birmingham, Alabama, USA

Year:
1989
Language:
english
File:
PDF, 204 KB
english, 1989
42

Conference information

Year:
1989
Language:
english
File:
PDF, 63 KB
english, 1989
43

Conference programme

Year:
1989
Language:
english
File:
PDF, 162 KB
english, 1989
44

Epidemiology and control of sexually transmitted diseases: the global picture

Year:
1989
Language:
english
File:
PDF, 107 KB
english, 1989
45

Immunological principles of vaccine design

Year:
1989
Language:
english
File:
PDF, 107 KB
english, 1989
46

Selection and suitability of adjuvants

Year:
1989
Language:
english
File:
PDF, 107 KB
english, 1989
47

Problems and prospects for the development of a vaccine against gonorrhoea

Year:
1989
Language:
english
File:
PDF, 106 KB
english, 1989
52

Specificity of serum immunoglobulin G subclass response to gonorrhoea in women

Year:
1989
Language:
english
File:
PDF, 113 KB
english, 1989
53

Development of a vaccine for gonorrhoea

Year:
1989
Language:
english
File:
PDF, 228 KB
english, 1989
54

Protective capacity of a ribosomal vaccine against Candida albicans

Year:
1989
Language:
english
File:
PDF, 114 KB
english, 1989
55

Immunity to chlamydial infections and the outlook for vaccination

Year:
1989
Language:
english
File:
PDF, 114 KB
english, 1989
56

Presentation of Chlamydia trachomatis epitopes on a poliovirus vaccine vector

Year:
1989
Language:
english
File:
PDF, 114 KB
english, 1989
57

Neutralizing epitopes on the major outer membrane protein of Chlamydia trachomatis

Year:
1989
Language:
english
File:
PDF, 113 KB
english, 1989
59

Stability and safety of a chlamydial live vaccine against enzootic abortion of ewes

Year:
1989
Language:
english
File:
PDF, 113 KB
english, 1989
60

Cell- and serum-mediated protection against Chlamydia psittaci infection of the mouse

Year:
1989
Language:
english
File:
PDF, 218 KB
english, 1989
61

Seroprevalence of lymphogranuloma venereum agents in northern Nigeria: a preliminary study

Year:
1989
Language:
english
File:
PDF, 103 KB
english, 1989
64

Production of recombinant Chlamydia trachomatis serovar D major outer membrane protein

Year:
1989
Language:
english
File:
PDF, 230 KB
english, 1989
67

Sexually-transmitted disease vaccine requirements: a US perspective

Year:
1989
Language:
english
File:
PDF, 97 KB
english, 1989
68

International testing of vaccine candidates for HIV: scientific, ethical and legal aspects

Year:
1989
Language:
english
File:
PDF, 97 KB
english, 1989
69

Current and future hepatitis B vaccines

Year:
1989
Language:
english
File:
PDF, 97 KB
english, 1989
70

Development and Clinical studies with a recombinant DNA hepatitis B vaccine

Year:
1989
Language:
english
File:
PDF, 197 KB
english, 1989
71

ISCOM technology and the presentation of synthetic peptides

Year:
1989
Language:
english
File:
PDF, 99 KB
english, 1989
72

Immunogenicity of peptide fusions to hepatitis B core antigen

Year:
1989
Language:
english
File:
PDF, 99 KB
english, 1989
73

Sustained release immunity from adjuvanted vaccines

Year:
1989
Language:
english
File:
PDF, 99 KB
english, 1989
74

Recombinant hepatitis B surface antigen (Re-HBs)

Year:
1989
Language:
english
File:
PDF, 80 KB
english, 1989
75

A vaccine to genital papillomaviruses: is it feasible?

Year:
1989
Language:
english
File:
PDF, 80 KB
english, 1989
76

Expression of human papillomavirus genes in cervical tissue and their roles in malignant transformation

Year:
1989
Language:
english
File:
PDF, 80 KB
english, 1989
79

Herpes simplex vaccines, current status and future prospects

Year:
1989
Language:
english
File:
PDF, 99 KB
english, 1989
83

Efficacy of purified herpes virus glycoprotein vaccines in animal models

Year:
1989
Language:
english
File:
PDF, 103 KB
english, 1989
84

Report on follow-up of consorts at risk immunized with Skinner vaccine

Year:
1989
Language:
english
File:
PDF, 103 KB
english, 1989
88

Evaluation in animal models of genetically engineered herpes simplex virus R7020, a prototype HSV vaccine

Year:
1989
Language:
english
File:
PDF, 93 KB
english, 1989
89

Effect of formalin treatment on antigenicity of herpes simplex virus type 1 glycoprotein D

Year:
1989
Language:
english
File:
PDF, 109 KB
english, 1989
90

Preparation of immune complex herpes simplex vaccine using human sera

Year:
1989
Language:
english
File:
PDF, 109 KB
english, 1989
91

Glycosylated and non-glycosylated proteins of HSV-1: relevance to vaccine development

Year:
1989
Language:
english
File:
PDF, 109 KB
english, 1989
92

Preparation of a subunit vaccine against herpes simplex

Year:
1989
Language:
english
File:
PDF, 109 KB
english, 1989
93

HIV antigens and their variability

Year:
1989
Language:
english
File:
PDF, 92 KB
english, 1989
94

Immunology of HIV

Year:
1989
Language:
english
File:
PDF, 92 KB
english, 1989
95

Studies on vaccination against HIV and FIV

Year:
1989
Language:
english
File:
PDF, 92 KB
english, 1989
97

Towards an AIDS vaccine - recombinant Ty: HIV virus-like particles

Year:
1989
Language:
english
File:
PDF, 102 KB
english, 1989
99

Potential of the anti-idiotype approach for the development of an anti-HIV vaccine

Year:
1989
Language:
english
File:
PDF, 102 KB
english, 1989
103

Preliminary studies towards the development of a subunit cytomegalovirus vaccine

Year:
1989
Language:
english
File:
PDF, 180 KB
english, 1989
104

Potential of immunosomes, liposomes and virosomes in infections with HIV

Year:
1989
Language:
english
File:
PDF, 80 KB
english, 1989
105

Novel reactors for vaccines

Year:
1989
Language:
english
File:
PDF, 80 KB
english, 1989
106

Calendar

Year:
1989
Language:
english
File:
PDF, 111 KB
english, 1989